{"id":130413,"date":"2025-08-13T13:55:45","date_gmt":"2025-08-13T21:55:45","guid":{"rendered":"https:\/\/xira.com\/p\/2025\/08\/13\/texas-sues-eli-lilly-big-pharma-compromised-medical-decision-making\/"},"modified":"2025-08-13T13:55:45","modified_gmt":"2025-08-13T21:55:45","slug":"texas-sues-eli-lilly-big-pharma-compromised-medical-decision-making","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2025\/08\/13\/texas-sues-eli-lilly-big-pharma-compromised-medical-decision-making\/","title":{"rendered":"Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’"},"content":{"rendered":"

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its most profitable drugs, including the high-demand GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment.<\/p>\n

\"\"<\/p>\n

\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\u00a0<\/div>\n

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its most profitable drugs, including the high-demand GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment.<\/p>\n

\"\"<\/p>\n

\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\"\"<\/a>\u00a0\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its most profitable drugs, including the high-demand GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to […]<\/p>\n","protected":false},"author":3,"featured_media":130414,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-130413","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-com"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/xira.com\/p\/wp-content\/uploads\/2025\/08\/legal-news-u6yYes.jpg?fit=767%2C505&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/130413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=130413"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/130413\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media\/130414"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=130413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=130413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=130413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}